Cholesterol-lowering statin drug fraud exposed in Australia
The words “cholesterol-lowering statin drugs” seem to be hotly debated these days, with both sides of the fence making their case for whether or not they’re safe. However, it wasn’t until recently that ABC News Australia decided to do the unthinkable and take on “big pharma” over allegations of racketeering within the industry.
Daring or not, ABC decided to go where NO other media company has gone before – not even the ones in the US pharmaceutical basement in the US, and that may even go to the government.
The investigative documentary:
Interviewed cardiologists revealed the cholesterol-lowering statin frauds and the enormous criminal activity within the industry that has allowed this “dangerous class of drug” to become one of the best-selling drugs of all time. Statements were made to the effect that NO study out of more than 27 previously conducted showed that patients taking statins will actually live longer than if they were not taking them at all.
“A modern fraud is now coming to light” Was proclaimed.
A week ago, in part 1 of “The Heart of the Matter” airing on ABC Australia, Emily Banks (Australia’s leading expert on drug safety) urged ABC not to air the follow-up part 2 because it might be too much of a documentary. intense. for cholesterol-lowering statin users, as she feared some statin users would even start throwing them away (critics recommended a resting place for such a fraudulent drug), likely leading to deaths(?).
However, such scare tactics failed to sway the makers of the documentary, and part 2 aired. More than 40 million worldwide now take these types of cholesterol-lowering drugs under the guise of save lifes; however, it may all just be a “big hoax” as revealed, as Dr. Maryanne Demasi put the multibillion-dollar pharmaceutical industry under a microscope.
Conclusion: The information revealed that night was not only powerful in criticizing such drugs (and their failures), but also the industry as a whole (and the criminal and mafia activities into which they seem to mutate). Dr. Maryanne Demasi put the billion-dollar pharmaceutical industry under a microscope and asked: Who really benefits from taking cholesterol-lowering drugs?
The answer seemed to be – NOT to the patients for whom they are prescribed.